Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceonS Community Trial (ACT)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.